Lymphoma
6 competing products in clinical development for Lymphoma.
Pipeline by Phase
Phase 13
Phase 1/22
Phase 21
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Rituximab + Lenalidomide + Valemetostat | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |
| Nivolumab | Ono Pharmaceutical | Phase 2 | Completed | 35 |
| ASP4132 | Astellas Pharma | Phase 1 | Completed | 29 |
| E7766 | Eisai | Phase 1 | Terminated | 21 |
| HMPL-689 | HUTCHMED | Phase 1 | Terminated | 15 |
| Tomivosertib (eFT-508) | eFFECTOR Therapeutics | Phase 1/2 | Terminated | 14 |